1. |
Brookmeyer R, Johnson E, Ziegler-Graham K, et al. Forecasting the global burden of Alzheimer's disease[J]. Alzheimers Dement, 2007, 3(3):186-191.
|
2. |
张振馨. 认知功能障碍研究进展[J]. 中华内科杂志, 2005, 8(8):633-634.
|
3. |
Peri A, Serio M. Neuroprotective effects of the Alzheimer's disease-related gene seladin-1[J]. J Mol Endocrinol, 2008, 41(5):251-261.
|
4. |
Pamplona FA, Pandolfo P, Duarte FS, et al. Altered ecnotiondity leads to increased pain tolerance in amyloid beta (Abeta1-40) peptide-treated mice[J]. Behav Brain Res, 2010, 212(1):96-102.
|
5. |
欧陵斌, 梁长香. 阿尔茨海默病的致病因素和临床用药研究[J]. 检验医学与临床, 2011, 8(2):251-252.
|
6. |
Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer's disease:progress and problems on the road to therapeutics[J]. Science, 2002, 297(5580):353-356.
|
7. |
Rosenberg RN. Translational research on the way to effective therapy for Alzheimer disease[J]. Arch Gen Psychiatry, 2005, 62(11):1186-1192.
|
8. |
Lewczuk P, Esselmann H, Bibl M, et al. Tau protein phosphorylated at threonine 181 in CSF as a neurochemical biomarker in Alzheimer's disease:original data and review of the literature[J]. J Mol Neurosci, 2004, 23(1/2):115-122.
|
9. |
Cuijpers P. Depressive disorders in caregivers of dementia patients:a systematic review[J]. Aging Ment Health, 2005, 9(4):325-330.
|
10. |
Colucci L, Bosco M, Fasanaro AM, et al. Alzheimer's disease costs:what we know and what we should take into account[J]. J Alzheimers Dis, 2014, 42(4):1311-1324.
|
11. |
Gaugler JE, Kane RL, Kane RA, et al. The longitudinal effects of early behavior problems in the dementia caregiving career[J]. Psychol Aging, 2005, 20(1):100-116.
|
12. |
Nakano H, Inoue Y. Epidemiology and cause of epilepsy[J]. Nihon Rinsho, 2014, 72(5):785-789.
|
13. |
Verellen RM, Cavazos JE. Pathophysiological considerations of seizures, epilepsy, and status epilepticus in the elderly[J]. Aging Dis, 2011, 2(4):278-285.
|
14. |
Kubota H, Ishihara H, Langmann T, et al. Distribution and functional activity of P-glycoprotein and multidrug resistance-associated proteins in human brain microvascular endothelial cells in hippocampal sclerosis[J]. Epilepsy Res, 2006, 68(3):213-228.
|
15. |
Schwake M, Pusch M, Kharkovets T, et al. Surface expression and single channel properties of KCNQ2/KCNQ3, M-type K+ channels involved in epilepsy[J]. J Biol Chem, 2000, 275(18):13343-13348.
|
16. |
Blumcke I, Cross JH, Spreafico R. The international consensus classification for hippocampal sclerosis:an important step towards accurate prognosis[J]. Lancet Neurol, 2013, 12(9):844-846.
|
17. |
Kan AA, de Jager W, de Wit M, et al. Protein expression profiling of inflammatory mediators in human temporal lobe epilepsy reveals co-activation of multiple chemokines and cytokines[J]. J Neuroinflammation, 2012, 9:207.
|
18. |
李舜伟, 李焰生, 刘若卓, 等. 中国偏头痛诊断治疗指南[J]. 中国疼痛医学杂志, 2011, 17(2):65-86.
|
19. |
偏头痛诊断与防治专家共识组, 李焰生. 偏头痛诊断与防治专家共识[J]. 中华内科杂志, 2006, 45(8):694-696.
|
20. |
Berman N, Pliri V, Cui L, et al. Trigeminal ganglion neuropeptides cycle with ovarian steroids in a model of menstrual migraine[J]. Headache, 2002, 42:438.
|
21. |
Colson NJ, Lea RA, Quinlan S, et al. The estrogen receptor 1 G594A polymorphism is associated with migraine susceptibility in two independent case/control groups[J]. Neurogenetics, 2004, 5(2):129-133.
|